Learn more about approved factor VIII replacement therapy ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl].

This is information from a study of 13 previously treated adults with with severe hemophilia A that had the goal of comparing how long ALTUVIIIO, Adynovate ® [Antihemophilic Factor …

Explore how ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] works in the body. See detailed Safety Information.

This is information from a study of 13 previously treated adults with severe hemophilia A, that had the goal of comparing how long ALTUVIIIO, Adynovate ® [Antihemophilic Factor …

ALTUVIIIO ® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in …

Hemophilia A is an inherited disorder passed down from male or female parents that causes the clotting protein Factor VIII to be missing or not work properly. This is also referred to as Factor …

INDICATION ALTUVIIIO® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding …

Step 3: Allow the ALTUVIIIO vial and the prefilled diluent syringe to come to room temperature before use. Do not use external heat sources such as putting the vial or prefilled diluent …

Download tools and resources for your ALTUVIIIO journey, including a quick guide, infusion overview, patient services enrollment form, and doctor discussion guide.

The recommended prophylaxis regimen is 50 IU/kg every 7 days as directed by your doctor. In children under 6 years of age, the recommended regimen is 50 IU/kg administered once …